SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ntoufa Stavroula) "

Sökning: WFRF:(Ntoufa Stavroula)

  • Resultat 1-10 av 24
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Chatzouli, Maria, et al. (författare)
  • Heterogeneous Functional Effects of Concomitant B Cell Receptor and TLR Stimulation in Chronic Lymphocytic Leukemia with Mutated versus Unmutated Ig Genes
  • 2014
  • Ingår i: Journal of Immunology. - : The American Association of Immunologists. - 0022-1767 .- 1550-6606. ; 192:10, s. 4518-4524
  • Tidskriftsartikel (refereegranskat)abstract
    • We recently reported that chronic lymphocytic leukemia (CLL) subgroups with distinct clonotypic BCRs present discrete patterns of TLR expression, function, and/ or tolerance. In this study, to explore whether specific types of BCR/TLR collaboration exist in CLL, we studied the effect of single versus concomitant BCR and/or TLR stimulation on CLL cells from mutated (M-CLL) and unmutated CLL (U-CLL) cases. We stimulated negatively isolated CLL cells by using anti-IgM, imiquimod, and CpG oligodeoxynucleotide for BCR, TLR7, and TLR9, respectively, alone or in combination for different time points. After in vitro culture in the absence of stimulation, differences in p-ERK were identified at any time point, with higher p-ERK levels in U-CLL versus M-CLL. Pronounced p-ERK induction was seen by single stimulation in U-CLL, whereas BCR/TLR synergism was required in M-CLL, in which the effect was overall limited in scale. An opposite pattern was observed regarding induction of apoptosis, as studied by Western blotting for the cleaved fragment of poly(ADP-ribose) polymerase, and the active isoform of caspase-8, with M-CLL responding even to single stimulation, contrasting with U-CLL that showed minimal response. Our findings suggest that concomitant engagement of BCR and TLR leads to differential responses in CLL depending on the mutational status of the BCR. Differential intensity and duration of responses in M-CLL versus U-CLL indicates that the differences in signal transduction between the two subgroups may be primarily quantitative rather than qualitative.
  •  
3.
  • Ghia, Paolo, et al. (författare)
  • Crystallographic evidence of autologous recognition by a clonotypic B cell receptor in chronic lymphocytic leukemia
  • 2015
  • Ingår i: Leukemia and Lymphoma. - IRCCS Sci Inst San Raffaele, Div Expt Oncol, Milan, Italy. [Degano, Massimo] IRCCS Sci Inst San Raffaele, Dept Immunol Transplantat & Infect Dis, Biocrystallog Unit, Milan, Italy. [Duehren-von Minden, Marcus; Schneider, Dunja; Alkhatib, Alabbas] Univ Freiburg, Ctr Biol Signaling Studies, Fac Biol, D-79106 Freiburg, Germany. [Belhart, Rudolf; Jumaa, Hassan] Univ Ulm Klinikum, Ulm, Germany. [Ntoufa, Stavroula; Stamatopoulos, Kostas] Ctr Res & Technol, Inst Appl Biosci, Thessaloniki, Greece. [Chiorazzi, Nicholas] Feinstein Inst Med Res, Manhasset, NY USA. [Stamatopoulos, Kostas] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden. [Ghia, Paolo] Univ Milan, Osped San Raffaele, Dept Oncohematol, I-20127 Milan, Italy. [Ghia, Paolo] Univ Vita Salute San Raffaele, Milan, Italy.. - 1042-8194 .- 1029-2403. ; 56:S1, s. 110-111
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
4.
  •  
5.
  • Gounari, Maria, et al. (författare)
  • Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
  • 2015
  • Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 125:23, s. 3580-3587
  • Tidskriftsartikel (refereegranskat)abstract
    • Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immuno-sorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.
  •  
6.
  • Kanduri, Meena, 1974, et al. (författare)
  • A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
  • 2013
  • Ingår i: Epigenetics. - : Informa UK Limited. - 1559-2294 .- 1559-2308. ; 8:12, s. 1280-8
  • Tidskriftsartikel (refereegranskat)abstract
    • The chromatin modifier EZH2 is overexpressed and associated with inferior outcome in mantle cell lymphoma (MCL). Recently, we demonstrated preferential DNA methylation of HOX genes in MCL compared with chronic lymphocytic leukemia (CLL), despite these genes not being expressed in either entity. Since EZH2 has been shown to regulate HOX gene expression, to gain further insight into its possible role in differential silencing of HOX genes in MCL vs. CLL, we performed detailed epigenetic characterization using representative cell lines and primary samples. We observed significant overexpression of EZH2 in MCL vs. CLL. Chromatin immune precipitation (ChIP) assays revealed that EZH2 catalyzed repressive H3 lysine 27 trimethylation (H3K27me3), which was sufficient to silence HOX genes in CLL, whereas in MCL H3K27me3 is accompanied by DNA methylation for a more stable repression. More importantly, hypermethylation of the HOX genes in MCL resulted from EZH2 overexpression and subsequent recruitment of the DNA methylation machinery onto HOX gene promoters. The importance of EZH2 upregulation in this process was further underscored by siRNA transfection and EZH2 inhibitor experiments. Altogether, these observations implicate EZH2 in the long-term silencing of HOX genes in MCL, and allude to its potential as a therapeutic target with clinical impact.
  •  
7.
  • Kanduri, Meena, 1974, et al. (författare)
  • Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.
  • 2012
  • Ingår i: Epigenetics. - : Informa UK Limited. - 1559-2294 .- 1559-2308. ; 7:12, s. 1435-42
  • Tidskriftsartikel (refereegranskat)abstract
    • Chronic lymphocytic leukemia (CLL) can be divided into prognostic subgroups based on the IGHV gene mutational status, and is further characterized by multiple subsets of cases with quasi-identical or stereotyped B cell receptors that also share clinical and biological features. We recently reported differential DNA methylation profiles in IGHV-mutated and IGHV-unmutated CLL subgroups. For the first time, we here explore the global methylation profiles of stereotyped subsets with different prognosis, by applying high-resolution methylation arrays on CLL samples from three major stereotyped subsets: the poor-prognostic subsets #1 (n = 15) and #2 (n = 9) and the favorable-prognostic subset #4 (n = 15). Overall, the three subsets exhibited significantly different methylation profiles, which only partially overlapped with those observed in our previous study according to IGHV gene mutational status. Specifically, gene ontology analysis of the differentially methylated genes revealed a clear enrichment of genes involved in immune response, such as B cell activation (e.g., CD80, CD86 and IL10), with higher methylation levels in subset #1 than subsets #2 and #4. Accordingly, higher expression of the co-stimulatory molecules CD80 and CD86 was demonstrated in subset #4 vs. subset #1, pointing to a key role for these molecules in the crosstalk of CLL subset #4 cells with the microenvironment. In summary, investigation of three prototypic, stereotyped CLL subsets revealed distinct DNA methylation profiles for each subset, which suggests subset-biased patterns of transcriptional control and highlights a key role for epigenetics during leukemogenesis.
  •  
8.
  • Kontopoulos, Efstratios, et al. (författare)
  • Studying the Cohesion Evolution of Genes Related to Chronic Lymphocytic Leukemia Using Semantic Similarity in Gene Ontology and Self-Organizing Maps
  • 2016
  • Ingår i: Proceedings of SWAT4LS-16, 9th International Conference on Semantic Web Applications and Tools for Life Sciences.
  • Konferensbidrag (refereegranskat)abstract
    • A significant body of work on biomedical text mining is aimed at uncovering meaningful associations between biological entities, including genes. This has the potential to offer new insights for research, uncovering hidden links between genes involved in critical pathways and processes. Recently, high-throughput studies have started to unravel the genetic landscape of chronic lymphocytic leukemia (CLL), the most common adult leukemia. CLL displays remarkable clinical heterogeneity, likely reflecting its underlying biological heterogeneity which, despite all progress, still remains insufficiently characterized and understood. This paper deploys an ontology-based semantic similarity combined with self-organizing maps for studying the temporal evolution of cohesion among CLL-related genes and the extracted information. Three consecutive time periods are considered and groups of genes are derived therein. Our preliminary results indicated that our proposed gene groupings are meaningful and that the temporal dimension indeed impacted the gene cohesion, leaving a lot of room for further promising investigations.
  •  
9.
  • Ljungström, Viktor, et al. (författare)
  • Whole-exome sequencing in relapsing chronic lymphocytic leukemia : clinical impact of recurrent RPS15 mutations
  • 2016
  • Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 127:8, s. 1007-1016
  • Tidskriftsartikel (refereegranskat)abstract
    • Fludarabine, cyclophosphamide and rituximab (FCR) is first-line treatment for medically fit chronic lymphocytic leukemia (CLL) patients, however despite good response rates many patients eventually relapse. Whilst recent high-throughput studies have identified novel recurrent genetic lesions in adverse-prognostic CLL, the mechanisms leading to relapse after FCR therapy are not completely understood. To gain insight into this issue, we performed whole-exome sequencing of sequential samples from 41 CLL patients who were uniformly treated with FCR but relapsed after a median of 2 years. In addition to mutations with known adverse-prognostic impact (TP53, NOTCH1, ATM, SF3B1, NFKBIE, BIRC3) a large proportion of cases (19.5%) harbored mutations in RPS15, a gene encoding a component of the 40S ribosomal subunit. Extended screening, totaling 1119 patients, supported a role for RPS15 mutations in aggressive CLL, with one-third of RPS15-mutant cases also carrying TP53 aberrations. In most cases selection of dominant, relapse-specific subclones was observed over time. However, RPS15 mutations were clonal prior to treatment and remained stable at relapse. Notably, all RPS15 mutations represented somatic missense variants and resided within a 7 amino-acid evolutionarily conserved region. We confirmed the recently postulated direct interaction between RPS15 and MDM2/MDMX and transient expression of mutant RPS15 revealed defective regulation of endogenous p53 compared to wildtype RPS15. In summary, we provide novel insights into the heterogeneous genetic landscape of CLL relapsing after FCR treatment and highlight a novel mechanism underlying clinical aggressiveness involving a mutated ribosomal protein, potentially representing an early genetic lesion in CLL pathobiology.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 24
Typ av publikation
tidskriftsartikel (18)
annan publikation (2)
konferensbidrag (2)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (17)
övrigt vetenskapligt/konstnärligt (7)
Författare/redaktör
Stamatopoulos, Kosta ... (24)
Ntoufa, Stavroula (24)
Ghia, Paolo (19)
Papakonstantinou, Ni ... (15)
Rosenquist, Richard (14)
Mansouri, Larry (8)
visa fler...
Agathangelidis, Andr ... (8)
Sutton, Lesley-Ann (8)
Pospisilova, Sarka (8)
Oscier, David (8)
Davi, Frederic (7)
Belessi, Chrysoula (7)
Davis, Zadie (7)
Anagnostopoulos, Ach ... (7)
Plevova, Karla (7)
Rossi, Davide (7)
Gaidano, Gianluca (7)
Langerak, Anton W. (6)
Baliakas, Panagiotis (6)
Gounari, Maria (6)
Stavroyianni, Niki (6)
Smedby, Karin E. (5)
Chiorazzi, Nicholas (5)
Young, Emma (5)
Muzio, Marta (5)
Scarfo, Lydia (4)
Juliusson, Gunnar (4)
Moysiadis, Theodoros (4)
Ljungström, Viktor (4)
Chartomatsidou, Elis ... (4)
Campo, Elias (3)
Ek, Sara (3)
Isaksson, Anders (3)
Panagiotidis, Panagi ... (3)
Strefford, Jonathan ... (3)
Bhoi, Sujata (3)
Kotta, Konstantia (3)
Pott, Christiane (3)
Hadzidimitriou, Anas ... (2)
Chu, Charles C. (2)
Kanduri, Meena, 1974 (2)
Apollonio, Benedetta (2)
Papazoglou, Despoina (2)
Xochelli, Aliki (2)
Chatzouli, Maria (2)
Trentin, Livio (2)
Ranghetti, Pamela (2)
Stilgenbauer, Stepha ... (2)
Castellano, Giancarl ... (2)
Schuh, Anna (2)
visa färre...
Lärosäte
Uppsala universitet (22)
Karolinska Institutet (6)
Lunds universitet (5)
Göteborgs universitet (2)
Högskolan i Borås (1)
Språk
Engelska (24)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (23)
Naturvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy